SCHEMBL10101643

SCHEMBL10101643

CC(=O)Oc1cc2c(cc1Cl)C1(OC(=O)c3ccccc31)c1cc(C34OOC(C)(c5ccccc53)C3C=CC=CC34)c(OC(C)=O)cc1O2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
HTT P42858 3/20 0.47
LMNA P02545 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
USP2 O75604 1/20 0.47
ALDH1A1 P00352 1/20 0.47
GSTP1 P09211 1/20 0.38
FTO Q9C0B1 3/20 0.37
PRMT1 Q99873 2/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
BLM P54132 1/20 0.37
SMAD3 P84022 1/20 0.37
ACE2 Q9BYF1 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP3A4 P08684 1/20 0.35
ALOX12 P18054 2/20 0.33
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10101817 0.85 MAPT (0.49) MAPTHTTLMNAMEN1KMT2A
SCHEMBL29349570 0.82 MAPT (0.66) MAPTHTTLMNAMEN1KMT2A
SCHEMBL1024927 0.82 MAPT (0.66) MAPTHTTLMNAMEN1KMT2A
SCHEMBL10100294 0.79 MAPT (0.53) MAPTHTTLMNAMEN1KMT2A
SCHEMBL10145450 0.76 MAPT (0.58) MAPTHTTLMNAMEN1KMT2A
SCHEMBL18184153 0.74 MAPT (0.58) MAPTHTTLMNAMEN1KMT2A
SCHEMBL10100273 0.72 MAPT (0.53) MAPTHTTLMNAMEN1KMT2A
SCHEMBL14005748 0.72 MAPT (0.54) MAPTHTTLMNAMEN1KMT2A
SCHEMBL18184154 0.72 MAPT (0.55) MAPTHTTLMNAMEN1KMT2A
SCHEMBL13914140 0.71 MAPT (0.67) MAPTHTTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173698-B2 Fluorescent probes; solid phase synthesis; kits Life Technologies Corporation (US) 2012-05-08 US disclosed
US-20080160627-A1 Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection INVITROGEN CORPORATION (US) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080160627-A1 Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection PPOX, HSPE1, PRDX3 MAPT 1442/4885HTT 2953/4885LMNA 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.